# Alcon Inc.

Type: Company (ALC)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/alcon-inc
Canonical HTML page: https://getbiobrief.com/entity/alcon-inc

## Recent coverage (1 stories)

### Alcon core EPS up 9% to $0.84; PowerVision charge $402M
2026-08-18 00:44:12 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Alcon posted 7% constant-currency sales growth and raised full-year core EPS guidance to 12-15% growth, but took a $402M noncash charge to discontinue PowerVision. Hims & Hers added branded weight-loss momentum with $753M revenue.
Full story: https://getbiobrief.com/story/bio-alcon-q2-2026-power-vision

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.